Abstract 11010: Serum Sphingolipids Level as a Novel Potential Indicator for Early Detection of Cardiac Ischemia

Ludwig Neyses , Farzin Fath-Ordoubadi , Magdi El-Omar , Valentine Charlton-Menys
Circulation 122

2010
2008
Abstract 3942: Serum Metabolomics Identifies Novel Signature Metabolites in Very Early Cardiac Ischaemia: First in Human Study

Ludwig Neyses , Farzin Fath-Ordoubadi , Magdi El-Omar , Dave Broadhurst
Circulation 120

1
2009
Physical activity as heart failure therapy: Patient perspectives

L Neyses , H Elwers , C Deaton , M Mamas
In: Spring Meeting on Cardiovascular Nursing, European Society of Cardiology; 01 Apr 2011-03 Apr 2011; Brussels. 2011.

2011
as part of a mechanism protecting cardiomyocytes against ischemic cell injury 2

Farzin Fath-Ordoubadi , Elizabeth J. Cartwright , Mohamed Shaheen , Mamas A. Mamas

2011
Quinoline and acridine derivatives as antiarrhythmic agents

Mamas Mamas , Derek Terrar , Edward Gill

1998
Major Bleeding and Adverse Outcome following Percutaneous Coronary Intervention

Mamas A Mamas , Douglas G Fraser , James Nolan , Chee W Khoo
Journal - Major Bleeding and Adverse Outcome following Percutaneous Coronary Intervention

2014
Treatment of Bifurcation coronary artery disease with the dedicated capella sideguard stent

Fath-Ordoubadi F , Mamas Ma
Interventional Cardiology 36 -38

2011
Late outcomes of drug eluting and bare metal stents in saphenous vein graft percutaneous coronary intervention

Neyses L , FAth-Ordoubadi F , El-Omar M , Mamas Ma
Eurointervention. 2010;:In Press.

2010
Serum Sphingolipids Level as a Novel Potential Indicator for Early Detection of Cardiac Ischemia

L Neyses , F Fath-Ordoubadi , M El-Omar , V Charlton-Menys
Circulation 122

1
2010
Review Article What are the Thromboembolic Risks of Heart Failure Combined With Chronic or Paroxysmal AF

Ludwig Neyses , Mamas A. Mamas , Jane Cochrane Caldwell , Clifford J. Garratt

2010